Volume 12, Number 9—September 2006
Dispatch
Lookback Exercise with Imported Crimean-Congo Hemorrhagic Fever, Senegal and France
Arnaud Tarantola*
, Pierre Nabeth†, Pierre Tattevin‡, Christian Michelet‡, Hervé Zeller§, and for the Incident Management Group
, Pierre Nabeth†, Pierre Tattevin‡, Christian Michelet‡, Hervé Zeller§, and for the Incident Management Group
Table 1
Synopsis of phases, risks, and management of case of Crimean-Congo hemorrhagic fever*
| Institution/phase | Place/date | Contacts, persons at risk | Measures | No. contacts (N = 181) | Responsible |
|---|---|---|---|---|---|
| Incubation phase | Senegal/Oct–Nov 2 | Contacts in Saly, Senegal | SOS Médecins Saly informed. | 2 | IPD and DIT-InVS |
| Before hospitalization | Dakar, Senegal/Nov 2–4 | Radiologist and his family | Radiologist informed | 5 | IPD and DIT-InVS |
| Hospitalization 1 | Dakar, Senegal/Nov 4–10 | HCWs and laboratory personnel | Head physicians informed and agreed to verify staff health status | 20 | IPD and DIT-InVS |
| Patients who shared the room | Head physicians informed and agreed to verify patient health status | 4 | IPD and DIT-InVS | ||
| Other physicians in health clinics welcoming expatriates informed | IPD and DIT-InVS | ||||
| Dental appointment | Dentist informed | 1 | IPD and DIT-InVS | ||
| Visitors (friends) | Physician and radiologist informed | 10 | IPD and DIT-InVS | ||
| Ambulance transport 1 | Dakar, Senegal/Nov10 | Personnel who transported the patient | Head physicians informed and agreed to verify staff health status | 2 | IPD and DIT-InVS |
| Hospitalization 2 | Dakar, Senegal/Nov 10–13 | HCWs who provided care | Head physicians informed and agreed to verify staff health status | 25 | IPD and DIT-InVS |
| Ambulance transport 2 | Dakar, Senegal/Nov 13 | Personnel who transported the patient | Head physicians informed and agreed to verify staff health status | 2 | IPD and DIT-InVS |
| Medical transport plane | Plane Dakar-Paris/Nov 13–14 | German team who provided care | Head physician informed and agreed to verify staff health status; German health authorities informed | 2 | DIT-InVS |
| Ambulance transport 3 | Rennes, France/Nov 14 | Personnel who transported the patient | Identification of contacts. Daily clinical follow up of contacts until Nov 26 | 2 | Ddass 35 and CIRE Quest |
| Hospitalization 3 | Rennes, France/Nov 14–24 | ICU personnel who provided care | Identification of contacts. Daily clinical follow up of contacts until Nov 26 | 34 | C-Clin Ouest, Ddass 35 and CIRE Ouest |
| ID personnel who provided care | Identification of contacts. Daily clinical follow up of contacts until Nov 26 | 10 | C-Clin Ouest, Ddass 35 and CIRE Ouest | ||
| Personnel who transported the patient between wards | Identification of contacts. Daily clinical follow up of contacts until Nov 26 | 3 | C-Clin Ouest, Ddass 35 and CIRE Ouest | ||
| Laboratory personnel | Identification of contacts. Daily clinical follow up of contacts until Nov 26; identification/tracing of samples | 50 | C-Clin Ouest, Ddass 35 and CIRE Ouest | ||
| Patient's family who visited | Identification of contacts. Daily follow up of contacts by telephone until Nov 26 | 9 | C-Clin Ouest, Ddass 35 and CIRE Ouest |
*HCW, healthcare workers; ICU, intensive care unit; ID, infectious diseases department; IPD, Institut Pasteur, Dakar; DIT, Département International et Tropical; InVS, Institut de Veille Sanitaire; CIRE, Cellule Interrégionale d'Epidémiologie.
1The members of the incident management group were (in alphabetical order) M. Aupée, J.-L. Avril, C. Bailly, B. Branger, J. Dissais, D. Escourolle, R. Garlantezec, S. Ioos, S. Jauréguiberry, C. Laguitton, M. Lampérier, R. le Goff, A. Lepoutre, G. Manet, M. Marquis, C. Michelet, P. Nabeth, C. Paquet, M.-C. Paty, C. Picot, H. Sénéchal, A. Tall, A. Tarantola, P. Tattevin, S. Veyrat, and H. Zeller.
Page created: November 17, 2011
Page updated: November 17, 2011
Page reviewed: November 17, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.